Profound Medical Set to Join Lake Street's Best Ideas Conference
Profound Medical Set to Join Lake Street's Best Ideas Conference
TORONTO – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a leader in the development of innovative medical devices, has announced its participation in one of the most anticipated events this season, the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference. The event is scheduled for September 12, 2024, in New York City.
What to Expect at the Conference
The format of this conference will feature individual meetings between the company’s management and investors. While there will not be a webcast available this year, the meetings will provide a valuable opportunity for interested parties to learn more about Profound Medical’s growth strategy and its pioneering technologies.
Innovative Therapies Offered by Profound Medical
As a commercial-stage medical device company, Profound Medical focuses on creating customizable and incision-free therapies. One of its key products is the TULSA-PRO system, a cutting-edge technology that merges real-time MRI guidance with robotically-driven transurethral ultrasound and advanced temperature feedback control. This innovative system enables the precise treatment of prostate disease, accessible for patients across varying risk profiles.
The TULSA Procedure
The TULSA procedure is particularly noteworthy due to its ability to deliver tailored treatment options suited to individual patient needs. By using real-time MRI for pixel-perfect accuracy, the system aims to minimize damage to surrounding tissues, thereby preserving urinary continence and sexual function when treating prostate conditions. The procedure itself is notably efficient, completed in a single session that typically lasts just a few hours, with patients often experiencing minimal recovery time.
Expanding Market Reach with Sonalleve
In addition to TULSA-PRO, Profound Medical is advancing the Sonalleve system, designed for non-invasive treatment of uterine fibroids and managing palliative pain associated with bone metastases. The technology is CE marked in Europe and has secured approval from the China National Medical Products Administration, making it a significant player in the market. There are plans for further exploration of potential treatments, particularly in the realm of non-invasive abdominal cancer therapy.
Future Innovations and Explorations
Profound Medical has its sights set on broadening the applications of both TULSA and Sonalleve technologies. The ongoing research aims to enhance existing treatments and uncover new avenues where these innovative solutions can make a difference, particularly in oncology.
Connecting with Profound Medical
For anyone interested in learning more about Profound Medical and its innovative solutions, please reach out to Stephen Kilmer, who leads investor relations. You can contact him at 647.872.4849 or via email. Profound Medical is committed to pushing the boundaries of what is possible in medical care, ensuring patients receive cutting-edge, effective treatments without the complexities of traditional methods.
Frequently Asked Questions
What is the purpose of the Lake Street Conference?
The conference provides a platform for companies like Profound Medical to meet with investors and discuss their business strategies and innovations.
What are the key products of Profound Medical?
Profound Medical focuses on TULSA-PRO and Sonalleve, both of which offer innovative approaches to treating prostate diseases and uterine fibroids, respectively.
How does the TULSA procedure work?
The TULSA procedure utilizes real-time MRI guidance and ultrasound to precisely target and treat prostate tissue while preserving surrounding areas.
What approvals does Sonalleve hold?
Sonalleve is CE marked in Europe, approved in China, and holds a Humanitarian Device Exemption from the FDA for specific treatments.
Who can I contact for more information about Profound Medical?
For more information, Stephen Kilmer from investor relations can be reached by phone or email.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Investigation into Stronghold Digital Mining's Proposed Merger
- Strider Technologies Expands Global Presence with Tokyo Office
- Transform Your Future: $100 in Icon's Stock Worth Today
- Mastercard's Impressive Growth: A 15-Year Journey to Wealth
- Sweetgreen's Tech Innovations Set to Boost Margins and EBITDA
- Investing in Ross Stores: A 15-Year Journey of Gains
- International Isotopes and Phantech Unveil PhanQual Innovation
- LendingClub's Strong Buy Upgrade: Implications for Investors
- Exro Technologies Inc. Plans Public Offering Up to $30 Million
- Serina Therapeutics to Showcase Innovation at Upcoming Conference
- How the Rating Boost Will Benefit Build-A-Bear Investors
- Investors Encouraged to Join Indivior PLC Class Action Lawsuit
- XPEL Investors Encouraged to Join Class Action Lawsuit
- Investors Can Lead Lawsuit Against Methode Electronics, Inc.
- International Flavors Soars to 52-Week High: Key Drivers Behind This Surge
- Corcept Therapeutics: Stock Surge and Future Prospects
- Kratos Defense: A Momentum Stock Worth Your Attention
- GM to Introduce Hybrid-Flex Vehicles in Brazil Soon
- Why Investors Are Eyeing Pearson as a Top Investment Choice
- Micron Technology's Stock Volatility: An Investor's Guide
- Evaluating the Future of Insulet Corp. and PODD Stock
- Exploring the Invesco Russell 1000 Dynamic Multifactor ETF
- Eli Lilly: Analyzing Its Momentum Stock Potential
- Jefferies: A Prominent Player in Momentum Stock Investing
- Chewy Stock Upgraded: Positive Earnings Outlook Ahead
Recent Articles
- Exploring the Strength of First Trust Mid Cap Growth ETF
- Descartes Systems Group Posts Impressive Q2 FY25 Results
- Copart Sees Drop in Shares After Q4 Earnings Miss Estimates
- Global Semiconductor Equipment Market Experiences Growth
- Streamline Health Set to Release Q2 2024 Financial Results
- Greif, Inc. Enhances Operations with New Facility in Malaysia
- DURECT Corporation Shares Insights at H.C. Wainwright Event
- EDP Renewables Honors Ten Milestones in Sustainable Energy Projects
- 10 Ten Gaming Launches an Exciting New Gaming Platform
- Melanated Cares Foundation Announces 2024 Melanated Campout
- Citi Forecasts 50bps Rate Cut Amid Labor Market Concerns
- U.S. Construction Spending Shows Unexpected Decline in June
- Headwall Investments Boosts Portfolio with Houston Acquisition
- Discover Daily Wisdom with Immergo's Innovative OTT Platform
- US Shapewear Market Growth Driven by Sustainability Needs
- Rescue Village's Woofstock Raises Over $100,000 for Animals
- IMF Report Highlights Growth Potential in Saudi Economy
- Montero Mining Awards Stock Options to Boost Development
- Bank of Canada Rate Cuts Expected to Continue Until Summer 2024
- Stonebridge Financial Partners with Wealthbox for CRM Solution
- Investigation of Better Choice, ARC, and CrossFirst Bankshares
- GoodWe Launches Innovative Energy Management Solutions at RE+
- Incode Technologies Appoints John Somorjai to Board
- Exploring the Future of China-Africa Relations at FOCAC Summit
- ITC Federal Secures Strategic Investment from Blue Delta Capital